Merck & Co., Inc. CEDEAR (MRKD)
BCBA
Closed
Oct 9, 2026
Day's Range
30.1952 wk Range
16.51Overview - MRKD - Merck & Co., Inc. CEDEAR
Key Statistics
Valuation
Enterprise Value
664.60B
P/E (Trailing)
‪44.25‬
Price / Book
‪14.55‬
EV / EBITDA
‪23.02‬
Profitability
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Float
19.70B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪29.26‬
200-Day Avg
‪25.07‬
Dividends
Frequency
Quarterly
Peers - MRKD - Merck & Co., Inc. CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- MRKDBCBAMerck & Co., Inc. CEDEAR+47.75%52-week change44.26P/E (Trailing)‪4.76%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR+38.30%52-week change11.00P/E (Trailing)‪21.48%‬Profit Margin
- GILDBCBAGilead Sciences Inc.+31.12%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.+35.08%52-week change4.90P/E (Trailing)‪18.87%‬Profit Margin
- LLYBCBAEli Lilly and Company CEDEAR+43.62%52-week change0.19P/E (Trailing)‪33.52%‬Profit Margin
- BIIBBCBABiogen Inc. CEDEAR+43.89%52-week change3.32P/E (Trailing)‪8.32%‬Profit Margin
- AMGNBCBAAmgen Inc. Cedear+39.00%52-week change0.18P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - MRKD - Merck & Co., Inc. CEDEAR
About
Merck & Co., Inc. CEDEAR is an Argentine depositary receipt that represents an economic interest in shares of Merck & Co., Inc., a global biopharmaceutical company focused on prescription medicines, vaccines, and animal health products. Its primary purpose is to provide local investors peso-denominated access to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
